ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(12): 157-164


In silico evaluation of Benzo (f) chromen-3-one as a potential inhibitor of NF-κB: A Key regulatory molecule in Inflammation-mediated pathogenesis of Diabetes, Alzheimer’s and Cancer

Sandeep Kumar Gandham, Venkata Ramaiah Chintha, Rajendra Wudayagiri.




Abstract

This study is aimed to evaluate the impact of Benzo (f) chromen-3-one, a plant compound present in Artemisia vulgaris, which was retrieved from pubchem database, as a NF-κB inhibitor, a key regulator found to be chronically activated in various ailments, such as Cancer, Diabetes, Rheumatoid Arthritis, Alzheimers and Inflammation etc. Molecular properties of the compound were analysed using Molinspiration and Swiss ADME servers. Molecular docking studies were performed followed by pathway analysis using STRING and KEGG databases. Docking results indicate grater binding affinity of the compound with NF-κB molecule. Molecular properties of the compound are in agreement with the Lipinski rule of five and also possess good pharmacological properties. Pathway analyses clarify the connecting link between various ailments in inflammation induced disease pathogenesis. Our computational analysis rationalizes the inhibitory ability of naturally occurring plant compound to alter the NF-κB signalling pathway. Docking studies substantiates the hypothesis that Benzo (f) chromen-3-one has significant potential to inhibit the NF-κB.

Key words: Benzo (f) chromen-3-one, NF-κB, Molecular docking, inflammation.





publications
0
supporting
0
mentioning
0
contrasting
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.



Bibliomed Article Statistics



12
11
12
21
22
23
20
28
26
18
27
10
R
E
A
D
S



13

8

11

15

13

5

10

9

11

25

21

4
D
O
W
N
L
O
A
D
S
0304050607080910111201020304
20242025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.


We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More Info Got It!